Luib, Armando R.
HRN: 25-45-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2024
CEFTRIAXONE 1G (VIAL)
07/08/2024
07/15/2024
IV
2g
Q24
Avulsed Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes